| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.09 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.09 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |